Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis

被引：10

作者：

Iñigo, P ^{[1
]}

Torregrosa, JV ^{[1
]}

Campistol, JM ^{[1
]}

Oppenheimer, F ^{[1
]}

机构：

[1] Univ Barcelona, Hosp Clin, Renal Transplant Unit, E-08036 Barcelona, Spain

来源：

TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 06期

关键词：

D O I：

10.1016/S0041-1345(99)00359-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2321 / 2321

页数：1

共 9 条

[1]

Ducloux D, 1998, TRANSPLANT INT, V11, P312

[2]

GASTON RS, 1994, AM J KIDNEY DIS, V24, P1

[3] EFFECTS OF ENALAPRIL ON ERYTHROCYTOSIS AFTER RENAL-TRANSPLANTATION [J].

GASTON, RS ;

JULIAN, BA ;

DIETHELM, AG ;

CURTIS, JJ .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (12) :954-955

[4] Losartan, an angiotensin-II receptor antagonist reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis [J].

Klaassen, RJL ;

VanGelder, T ;

RischenVos, J ;

Deinum, J ;

ManintVeld, AJ ;

Weimar, W .

TRANSPLANTATION, 1997, 64 (05) :780-782

[5] Angiotensin II stimulates proliferation of normal early erythroid progenitors [J].

Mrug, M ;

Stopka, T ;

Julian, BA ;

Prchal, JF ;

Prchal, JT .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2310-2314

[6] ERYTHREMIA AFTER RENAL TRANSPLANTATION [J].

NIES, BA ;

COHN, R ;

SCHRIER, SL .

NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (15) :785-&

[7]

TORREGROSA JV, 1994, TRANSPLANTATION, V58, P311, DOI 10.1097/00007890-199408000-00010

[8] POSTRENAL TRANSPLANT ERYTHROCYTOSIS - A REVIEW OF 53 PATIENTS [J].

WICKRE, CG ;

NORMAN, DJ ;

BENNISON, A ;

BARRY, JM ;

BENNETT, WM .

KIDNEY INTERNATIONAL, 1983, 23 (05) :731-737

[9] SUPPRESSION OF THE RENIN-ANGIOTENSIN ALDOSTERONE AXIS WITH ERYTHROPOIETIN THERAPY BY A NEGATIVE FEEDBACK LOOP [J].

YAQOOB, M ;

MORRIS, K ;

BELL, GM ;

AHMAD, R .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (02) :125-128

← 1 →